Rocket Pharmaceuticals Inc (RCKT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Operating Expenses | 54,210 | 42,564 | 44,332 | 49,646 | 34,048 |
| Operating Income | -54,210 | -42,564 | -44,332 | -49,646 | -34,048 |
| Interest Expense | 465 | 464 | 463 | 534 | 251 |
| Other Income | 273 | 46 | 548 | 62 | -226 |
| Pre-tax Income | -54,402 | -42,982 | -44,247 | -50,118 | -34,525 |
| Net Income Continuous | -54,402 | -42,982 | -44,247 | -50,118 | -34,525 |
| Net Income | $-54,402 | $-42,982 | $-44,247 | $-50,118 | $-34,525 |
| EPS Basic Total Ops | -0.83 | -0.67 | -0.68 | -0.79 | -0.55 |
| EPS Basic Continuous Ops | -0.83 | -0.67 | -0.69 | -0.79 | -0.55 |
| EPS Diluted Total Ops | -0.83 | -0.67 | -0.68 | -0.79 | -0.55 |
| EPS Diluted Continuous Ops | -0.83 | -0.67 | -0.69 | -0.79 | -0.55 |
| EBITDA(a) | $-51,667 | $-41,262 | $-41,147 | $-48,838 | $-33,342 |